It's more that the DC cells are going to pump out growth factors which will include the wnt proteins and all the others we hear about. My understanding of the major difference between Histogen and Replicel is that Replicel will inject the cells and let them express the genes and growth factors in vivo, whereas Histogen will culture the cells in the lab where gene expression and production of growth factors happens in vitro, then they inject the growth factors directly.
But as far as Replicel is concerned, basically there is going to be a hyper-expression of genes and growth factors in vivo such as hasn't been seen in the scalp since you were a developing embryo. Who knows what that might do? It SHOULD be okay but there might be unknown processes going on that nobody yet knows about. Better safe than sorry.
The other big unknown is the purity of the stem cells. We know that the cells have to go through several generations to make enough cells to be useful, and we know that in previous work the stem cells at the end of the process were not the same as the original stem cells - in particular they lost their inductive ability to generate hair, which is one major reason the original 10-year estimate blew out.
So what happens if there are mutations along the line? What if a mutation happens early on and carries down through billions of daughter cells? What if those cells now hyper-express a protein that causes cancer?
I'm not saying that's likely or even possible because I don't know, I'm not an expert (I am a scientist but not a bioscientist). All I'm saying is we are talking about a process that is associated with both embryo development and cancer. And even if there's no known pathway by which cancer could result (as the Replicel guys have said), that doesn't mean one doesn't exist, because this is brand new science - we need to go through the trials and Replicel obviously agree.
Even if some of us are desperate enough to take the risk we need to remember that any serious breach of safety standards could get Replicel into big trouble and send them out of business as well as get the whole industry under extra regulation - and then nobody gets treatment.
But as far as Replicel is concerned, basically there is going to be a hyper-expression of genes and growth factors in vivo such as hasn't been seen in the scalp since you were a developing embryo. Who knows what that might do? It SHOULD be okay but there might be unknown processes going on that nobody yet knows about. Better safe than sorry.
The other big unknown is the purity of the stem cells. We know that the cells have to go through several generations to make enough cells to be useful, and we know that in previous work the stem cells at the end of the process were not the same as the original stem cells - in particular they lost their inductive ability to generate hair, which is one major reason the original 10-year estimate blew out.
So what happens if there are mutations along the line? What if a mutation happens early on and carries down through billions of daughter cells? What if those cells now hyper-express a protein that causes cancer?
I'm not saying that's likely or even possible because I don't know, I'm not an expert (I am a scientist but not a bioscientist). All I'm saying is we are talking about a process that is associated with both embryo development and cancer. And even if there's no known pathway by which cancer could result (as the Replicel guys have said), that doesn't mean one doesn't exist, because this is brand new science - we need to go through the trials and Replicel obviously agree.
Even if some of us are desperate enough to take the risk we need to remember that any serious breach of safety standards could get Replicel into big trouble and send them out of business as well as get the whole industry under extra regulation - and then nobody gets treatment.
Comment